General Biologicals Corporation (4117.TWO)

TWD 12.75

(-24.33%)

Annual Balance Sheets

(In TWD)
Breakdown 2023 2022 2021 2020 2019
Total Assets 2.53 Billion 1.55 Billion 1.26 Billion 833.28 Million 281.3 Million
Total Current Assets 401.85 Million 550.97 Million 510.31 Million 608.9 Million 31.59 Million
Cash And Short Term Investments 217.12 Million 351.08 Million 369.81 Million 475.68 Million 31.59 Million
Cash and Cash Equivalents 217.12 Million 262.18 Million 308.77 Million 350.6 Million 29.96 Million
Short Term Investments - 88.89 Million 61.04 Million 125.08 Million 1.62 Million
Net Receivables 95.42 Million 79.82 Million 59.04 Million 67.76 Million 55.93 Million
Inventory 85.55 Million 116.79 Million 81.32 Million 64.85 Million 27.58 Million
Other Current Assets 3.75 Million 3.27 Million 139 Thousand 600 Thousand 11.71 Million
Total Non-Current Assets 2.13 Billion 999.59 Million 754.12 Million 224.37 Million 163.53 Million
Net PPE 2 Billion 864.45 Million 607.86 Million 126.09 Million 123.35 Million
Good Will And Intangible Assets 56.86 Million 61.76 Million 65.25 Million 62.58 Million 24.1 Million
Good Will 20.67 Million 20.67 Million 20.67 Million 44.05 Million -
Intangible Assets 36.18 Million 41.08 Million 44.58 Million 18.53 Million 24.1 Million
Long-Term Investments 38.16 Million -52.21 Million -22.52 Million -115.28 Million 9.12 Million
Tax Assets -38.16 Million 11.92 Million 18.9 Million 13.79 Million -
Other Non Current Assets 76.11 Million 113.67 Million 84.62 Million 137.17 Million 6.96 Million
Other Assets - - - - 86.17 Million
Total Liabilities 2.04 Billion 857.5 Million 529.78 Million 145.53 Million 209.42 Million
Total Current Liabilities 1.02 Billion 98.03 Million 77.06 Million 85.37 Million 126.09 Million
Account Payables 23.2 Million 23.99 Million 34 Million 35.98 Million 42.86 Million
Tax Payables - - - - -
Short Term Debt 170.37 Million 17.98 Million 15.72 Million 18.34 Million 40.62 Million
Deferred Revenue 821.41 Million 52.02 Million 24.63 Million 28.31 Million -
Other Current Liabilities 14.3 Million 4.04 Million 2.7 Million 2.72 Million 42.6 Million
Total Non Current Liabilities 1.01 Billion 759.46 Million 452.72 Million 60.16 Million 83.33 Million
Long-Term Debt 379.13 Million 452.14 Million 438.44 Million 50.8 Million 71.92 Million
Deferred Revenue Non Current - - - - -
Deferred Tax Liabilities Non Current - - - - -
Other Non Current Liabilities 627.35 Million 301.12 Million 8.79 Million 9.36 Million 11.4 Million
Other Liabilities - - - - -
Total Equity 496.64 Million 693.06 Million 734.65 Million 687.74 Million 71.87 Million
Stock Holders Equity 495.13 Million 690.52 Million 731.51 Million 684.54 Million 71.87 Million
Common Stock 598.24 Million 598.24 Million 598.24 Million 598.24 Million 398.56 Million
Retained Earnings -211.43 Million -12.63 Million 44.05 Million -316.35 Million -378.54 Million
Accumulated other comprehensive income 16.12 Million 12.7 Million 1.41 Million -1.49 Million -1.19 Million
Common Stock Equity 495.13 Million 690.52 Million 731.51 Million 684.54 Million 71.87 Million
Capital Lease Obligation 463.32 Million 462.11 Million 444.49 Million 55.74 Million 57.06 Million
Total Investments 38.16 Million 36.67 Million 38.51 Million 9.8 Million 1.62 Million
Total Debt 549.51 Million 470.13 Million 454.17 Million 69.15 Million 112.54 Million
Net Debt 332.38 Million 207.94 Million 145.39 Million -281.45 Million 82.58 Million

Balance Sheet Charts